Manchester Capital Management’s Zimmer Biomet ZBH Stock Holding History

Manchester Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78.5K	Buy	868 +18	+2%	+$1.65K	0.01%	409
2025 Q4	$76.4K	Buy	850 +53	+7%	+$5.03K	0.01%	419
2025 Q3	$78.5K	Buy	797 +9	+1%	+$892	0.01%	471
2025 Q2	$71.9K	Sell	788 -49	-6%	-$4.74K	0.01%	507
2025 Q1	$94.7K	Buy	837 +28	+3%	+$3K	0.01%	435
2024 Q4	$85.5K	Buy	809 +21	+3%	+$2.25K	0.01%	448
2024 Q3	$85.1K	Hold	788	–	–	0.01%	445
2024 Q2	$85.5K	Sell	788 -4	-0.5%	-$472	0.01%	428
2024 Q1	$105K	Buy	792 +9	+1%	+$1.12K	0.01%	401
2023 Q4	$95.3K	Buy	783 +24	+3%	+$2.68K	0.01%	365
2023 Q3	$85.2K	Hold	759	–	–	0.01%	367
2023 Q2	$111K	Hold	759	–	–	0.01%	341
2023 Q1	$98.1K	Hold	759	–	–	0.01%	367
2022 Q4	$96.8K	Hold	759	–	–	0.01%	323
2022 Q3	$79K	Hold	759	–	–	0.01%	322
2022 Q2	$80K	Hold	759	–	–	0.01%	331
2022 Q1	$97K	Sell	759 -23	-3%	-$2.77K	0.01%	340
2021 Q4	$96K	Hold	782	–	–	0.01%	345
2021 Q3	$111K	Hold	782	–	–	0.02%	346
2021 Q2	$122K	Hold	782	–	–	0.02%	311
2021 Q1	$122K	Hold	782	–	–	0.02%	310
2020 Q4	$117K	Hold	782	–	–	0.02%	300
2020 Q3	$103K	Sell	782 -808	-51%	-$106K	0.02%	281
2020 Q2	$184K	Hold	1,590	–	–	0.03%	246
2020 Q1	$156K	Hold	1,590	–	–	0.03%	250
2019 Q4	$231K	Hold	1,590	–	–	0.03%	230
2019 Q3	$212K	Hold	1,590	–	–	0.02%	228
2019 Q2	$182K	Hold	1,590	–	–	0.02%	244
2019 Q1	$197K	Hold	1,590	–	–	0.03%	232
2018 Q4	$172K	Hold	1,590	–	–	0.03%	226
2018 Q3	$203K	Hold	1,590	–	–	0.03%	225
2018 Q2	$172K	Hold	1,590	–	–	0.03%	230
2018 Q1	$168K	Hold	1,590	–	–	0.03%	222
2017 Q4	$186K	Hold	1,590	–	–	0.03%	207
2017 Q3	$181K	Hold	1,590	–	–	0.03%	196
2017 Q2	$198K	Hold	1,590	–	–	0.03%	193
2017 Q1	$189K	Hold	1,590	–	–	0.03%	198
2016 Q4	$159K	Hold	1,590	–	–	0.02%	209
2016 Q3	$201K	Sell	1,590 -11	-0.7%	-$1.36K	0.03%	189
2016 Q2	$187K	Hold	1,601	–	–	0.03%	200
2016 Q1	$166K	Hold	1,601	–	–	0.02%	218
2015 Q4	$159K	Hold	1,601	–	–	0.02%	241
2015 Q3	$146K	Hold	1,601	–	–	0.02%	239
2015 Q2	$170K	Hold	1,601	–	–	0.03%	226
2015 Q1	$182K	Sell	1,601 -1,010	-39%	-$115K	0.03%	208
2014 Q4	$288K	Sell	2,611 -309	-11%	-$32.6K	0.04%	276
2014 Q3	$285K	Hold	2,920	–	–	0.04%	259
2014 Q2	$294K	Buy	2,920 +760	+35%	+$74.2K	0.04%	274
2014 Q1	$198K	Hold	2,160	–	–	0.03%	340
2013 Q4	$195K	Sell	2,160 -10	-0.5%	-$865	0.03%	338
2013 Q3	$173K	Hold	2,170	–	–	0.03%	362
2013 Q2	$158K	Buy	+2,170	New	+$162K	0.03%	361

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manchester Capital Management's ZBH Position: Q1 2026 in Review

Manchester Capital Management increased its Zimmer Biomet (ZBH) stake by 2.1% in Q1 2026, buying an estimated $1.65K and bringing the position to 868 shares worth $78.5K. The position accounts for 0.01% of the portfolio, ranked #409.

Manchester Capital Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $294K in Q2 2014. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Manchester Capital Management held 868 shares of Zimmer Biomet worth $78.5K as of Q1 2026.
Manchester Capital Management bought 18 Zimmer Biomet shares in Q1 2026, an estimated $1.65K.
Zimmer Biomet made up 0.01% of Manchester Capital Management's portfolio in Q1 2026, its #409 holding.
Manchester Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
Manchester Capital Management's Zimmer Biomet position peaked at $294K in Q2 2014.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.